Lidocaine Hydrochloride Noridem

Lidocaine Hydrochloride, the active ingredient in Lidocaine Hydrochloride Noridem, is a local anesthetic presented as a sterile solution for epidural, infiltration and intradermal use. It provides reversible nerve block for minor surgical, diagnostic and analgesic procedures in adult patients. GNH USA supplies Lidocaine Hydrochloride Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine Hydrochloride is used in the local anesthetic class to temporarily block nerve transmission for various procedures. - Minor surgical or diagnostic procedures: provides rapid onset surface anesthesia for short‑duration interventions. - Epidural analgesia: delivers segmental pain relief during labor, obstetric or postoperative care. - Infiltration anesthesia: allows targeted numbness of tissues during suturing or minor excisions. - Intradermal anesthesia: facilitates painless skin testing or superficial dermatologic procedures.

Lidocaine Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Burning or stinging at the injection site. - Tingling or numbness extending beyond the target area. - Light‑headedness or dizziness. - Mild hypotension.

Serious or Rare Side Effects: - Allergic reactions such as rash, urticaria or anaphylaxis. - Central nervous system toxicity manifesting as seizures or loss of consciousness. - Cardiac arrhythmias, including ventricular tachycardia. - Methemoglobinemia leading to cyanosis and reduced oxygen delivery.

When using Lidocaine Hydrochloride, clinicians should observe several safety measures. - Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Dose minimization: employ the lowest effective concentration for the intended procedure. - Cardiovascular monitoring: watch for hypotension or arrhythmias, especially in high‑risk patients. - Hepatic function: use caution in patients with severe liver disease due to reduced metabolism. - Pregnancy considerations: avoid unless benefit outweighs potential risk, as data are limited. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Lidocaine Hydrochloride can interact with other medicines that affect cardiac conduction or drug metabolism.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide) – may potentiate cardiotoxicity. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) – increase systemic lidocaine levels. - Beta‑blockers – can enhance bradycardia and hypotensive effects.

Moderate Interactions (Monitor Closely): - Other local anesthetics – cumulative toxicity risk. - Diuretics (e.g., furosemide) – may lower plasma protein binding, raising free lidocaine. - Anticonvulsants – may alter seizure threshold when lidocaine toxicity occurs.